Federal Appeals Court Supports PMA Predominance Over State Suits
This article was originally published in The Gray Sheet
Executive Summary
A recent decision in the Second Circuit U.S. Court of Appeals reinforces the power of FDA PMA approval to take precedence over state tort claims
You may also be interested in...
Federal Preemption Defense Under Fire In Draft House Bills
A one-sentence provision tucked into draft legislation circulating in a House subcommittee seeks to weaken device and drug manufacturers' ability to claim FDA approval as a defense in state product liability lawsuits
Federal Preemption Defense Under Fire In Draft House Bills
A one-sentence provision tucked into draft legislation circulating in a House subcommittee seeks to weaken device and drug manufacturers' ability to claim FDA approval as a defense in state product liability lawsuits
Supreme Court Seeks Solicitor General’s Input On PMA Preemption
The U.S. Supreme Court is considering whether to hear a potentially far-reaching case on whether patients injured by PMA-approved devices can sue manufacturers under state laws